<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>DHEA (dehydroepiandrosterone) replacement is not part of the current standard of care in hypoadrenal subjects </plain></SENT>
<SENT sid="1" pm="."><plain>Animal studies have shown that DHEA administration prevents <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>To determine the physiological effect of DHEA replacement on insulin sensitivity in adrenal-deficient women, we performed a single-center, randomized, double-blind, placebo-controlled, crossover study in 28 hypoadrenal women (mean age 50.2 +/- 2.87 years) who received a single 50-mg dose of DHEA daily or placebo </plain></SENT>
<SENT sid="3" pm="."><plain>After 12 weeks, insulin sensitivity was assessed using a hyperinsulinemic-euglycemic clamp </plain></SENT>
<SENT sid="4" pm="."><plain>DHEA replacement significantly increased DHEA-S (sulfated <z:chebi fb="21" ids="35701">ester</z:chebi> of DHEA), bioavailable <z:chebi fb="51" ids="17347">testosterone</z:chebi>, and androstenedione and reduced <z:chebi fb="25" ids="50112">sex hormone</z:chebi>-binding globulin levels </plain></SENT>
<SENT sid="5" pm="."><plain>Fasting plasma insulin and glucagon were lower with DHEA (42 +/- 4.94 vs. 53 +/- 6.58 pmol/l [P = 0.005] and 178 +/- 11.32 vs. 195.04 +/- 15 pmol/l [P = 0.02], respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>The average amount of <z:chebi fb="105" ids="17234">glucose</z:chebi> needed to maintain similar blood <z:chebi fb="105" ids="17234">glucose</z:chebi> levels while infusing the same insulin dosages was higher during DHEA administration (358 +/- 24.7 vs. 320 +/- 24.6 mg/min; P &lt; 0.05), whereas endogenous <z:chebi fb="105" ids="17234">glucose</z:chebi> production was similar </plain></SENT>
<SENT sid="7" pm="."><plain>DHEA also reduced total cholesterol (P &lt; 0.005), <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (P &lt; 0.011), <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> (P &lt; 0.05), and <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> (P &lt; 0.005) </plain></SENT>
<SENT sid="8" pm="."><plain>In conclusion, replacement therapy with 50 mg of DHEA for 12 weeks significantly <z:mp ids='MP_0002891'>increased insulin sensitivity</z:mp> in hypoadrenal women, thereby suggesting that DHEA replacement could have a potential impact in preventing type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>